Products

CyAL-5 cRGD is a fluorescence imaging agent comprising a

potent cyclic RGD peptide, c(RGDfK) designed to target

integrins and a CyAL-5 dye with emission at 658 nm.

This agent has been developed to target αvβ3 expression in

the neovasculature as well as tumor cells, to monitor

angiogenesis and growth and treatment efficacy.

Ex max = 643 nm, Em max = 658 nm  

Cy3 cRGD is a fluorescence imaging agent comprising a

potent cyclic RGD peptide, c(RGDfK) designed to target

integrins and a Cy3 dye with emission at 565 nm.

This agent has been developed to target αvβ3 expression in

the neovasculature as well as on tumor cells, to monitor

angiogenesis and growth and treatment efficacy.

Abs max = 550 nm, FL Em max = 565 nm

cRGD-LC-fluorescein is a fluorescence imaging agent

comprising a potent cyclic RGD peptide, c(RGDfK) designed to

target integrins and a fluorescein molecule with fluorescence

emission at 519 nm.

This agent has been developed to target αvβ3 expression in

the neovasculature as well as on tumor cells, to monitor

angiogenesis and growth and treatment efficacy.

Abs max = 480 nm, FL Em max = 519 nm

CyAL-5 2-deoxyglucose (CyAl-5 2-DG) is a fluorescent

imaging agent designed to target a wide spectrum of cancers

such as breast, glioblastoma, colon and prostate in vitro as

well as in vivo.

Ex max = 643 nm, Em max = 661 nm